Hemodynamic Assessment Before and After Endovascular Therapy for Critical Limb Ischemia and Association With Clinical Outcomes
Conclusions A change in ABI and TBI from pre-procedural values provides prognostic value in determining which patients may have wound healing and reduced MALE. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Reed, G. W., Young, L., Bagh, I., Maier, M., Shishehbor, M. H. Tags: Peripheral Source Type: research

Endovascular-First Approach for Chronic Mesenteric Ischemia: The Critical Need for Reporting Standards and High-Grade Evidence
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Bisdas, T., Stavroulakis, K. Tags: Editorial Comment Source Type: research

Endovascular Versus Surgical Revascularization for Chronic Mesenteric Ischemia: Insights From the National Inpatient Sample Database
Conclusions In a large, retrospective analysis of patients with CMI, endovascular therapy remained the dominant revascularization modality, and was associated with lower rates of MACCE, composite in-hospital complications, lower costs, and shorter length of stay compared with surgery. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Lima, F. V., Kolte, D., Kennedy, K. F., Louis, D. W., Abbott, J. D., Soukas, P. A., Hyder, O. N., Mamdani, S. T., Aronow, H. D. Tags: Peripheral Source Type: research

The Transcatheter Aortic Valve Replacement Bounce-Back: Does it Matter? What Can Be Done?
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Hanzel, G. S. Tags: Editorial Comment Source Type: research

Incidence, Prognostic Impact, and Predictive Factors of Readmission for Heart Failure After Transcatheter Aortic Valve Replacement
Conclusions Readmission for CHF after TAVR was frequent and was strongly associated with 1-year mortality. Low gradient, persistent pulmonary hypertension, left atrial dilatation, and transfusions were predictive of readmission for CHF. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Durand, E., Doutriaux, M., Bettinger, N., Tron, C., Fauvel, C., Bauer, F., Dacher, J.-N., Bouhzam, N., Litzler, P.-Y., Cribier, A., Eltchaninoff, H. Tags: Structural Source Type: research

Transapical Approach: Learn From the Past, Move Toward the Future
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Hayashida, K., Yamamoto, M. Tags: Editorial Comment Source Type: research

Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial
Conclusions Compared with TF TAVR, TA TAVR is associated with a disproportionate risk of cardiac mortality in patients with LV dysfunction and with delayed and less robust improvement in LV function and overall functional status. Caution is warranted when considering TA access for structural heart disease interventions, particularly in patients with LV dysfunction. (Placement of Aortic Transcatheter Valves [PARTNER]; NCT00530894) (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Elmariah, S., Fearon, W. F., Inglessis, I., Vlahakes, G. J., Lindman, B. R., Alu, M. C., Crowley, A., Kodali, S., Leon, M. B., Svensson, L., Pibarot, P., Hahn, R. T., Thourani, V. H., Palacios, I. F., Miller, D. C., Douglas, P. S., Passeri, J. J., on beha Tags: Structural Source Type: research

Left Main Disease: At the Intersection of Surgery and Stents
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Kandzari, D. E., Moses, J. W. Tags: Editorial Comment Source Type: research

The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease
Conclusions After a median follow-up period of 17 months, PCI with new-generation drug-eluting stents was associated with an overall low rate of the composite endpoint of death, MI, or cerebrovascular accident. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Chieffo, A., Tanaka, A., Giustino, G., Briede, I., Sawaya, F. J., Daemen, J., Kawamoto, H., Meliga, E., DAscenzo, F., Cerrato, E., Stefanini, G. G., Capodanno, D., Mangiameli, A., Templin, C., Erglis, A., Morice, M. C., Mehran, R., Van Mieghem, N. M., Nak Tags: Coronary: Focus on Stent Technology Source Type: research

Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial
Conclusions PtCr-EES demonstrated comparable safety and effectiveness to CoCr-EES through 5 years of follow-up, with low rates of stent thrombosis and other adverse events. The 5-year event rates were also acceptable in patients with small vessels and long lesions treated with PtCr-EES. (The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions [PLATINUM]; NCT00823212; The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels [PLATINUM SV]; NCT01498692; The PLATINUM Clinical T...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Kelly, C. R., Teirstein, P. S., Meredith, I. T., Farah, B., Dubois, C. L., Feldman, R. L., Dens, J., Hagiwara, N., Rabinowitz, A., Carrie, D., Pompili, V., Bouchard, A., Saito, S., Allocco, D. J., Dawkins, K. D., Stone, G. W. Tags: Coronary: Focus on Stent Technology Source Type: research

Functionally Incomplete Re-Endothelialization of Stents and Neoatherosclerosis
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Arbustini, E., Favalli, V., Narula, J. Tags: Editorial Comment Source Type: research

Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents
Conclusions This is the first study to examine VE-cadherin expression after DES. All DES demonstrated deficient barrier expression relative to BMS with results favoring BP-SES versus DP-EES. These findings may have important implications for the development of neoatherosclerosis in different stent types. (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Mori, H., Cheng, Q., Lutter, C., Smith, S., Guo, L., Kutyna, M., Torii, S., Harari, E., Acampado, E., Joner, M., Kolodgie, F. D., Virmani, R., Finn, A. V. Tags: MOC Source Type: research

Early and Late Bioresorbable Vascular Scaffold Thrombosis: Size Matters
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Alvarez, M., Applegate, R. J. Tags: Editorial Comment Source Type: research

Characteristics, Predictors, and Mechanisms of Thrombosis in Coronary Bioresorbable Scaffolds: Differences Between Early and Late Events
Conclusions Different mechanisms underlie early and late ScT: although incomplete BRS deployment was a predictor of the former, the latter was associated with large vessel size and BRS undersizing. However, both phenomena are significantly less frequent with an optimized implantation technique. (Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry [MICAT]; NCT02180178) (Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Gori, T., Weissner, M., Gönner, S., Wendling, F., Ullrich, H., Ellis, S., Anadol, R., Polimeni, A., Münzel, T. Tags: Coronary: Focus on Stent Technology Source Type: research

Bioresorbable Scaffolds: A Complex Journey to the "Promised Land"
(Source: Journal of the American College of Cardiology: Cardiovascular Interventions)
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - December 4, 2017 Category: Cardiology Authors: Colombo, A., Azzalini, L. Tags: Editorial Comment Source Type: research